Gajdács M, Spengler G. The Role of Drug Repurposing in the Development of Novel Antimicrobial Drugs: Non-Antibiotic Pharmacological Agents as Quorum Sensing-Inhibitors. Antibiotics (Basel). 2019 Dec 17;8(4). pii: E270. doi: 10.3390/antibiotics8040270.

Gajdács M, Urbán E. Epidemiology and resistance trends of Staphylococcus aureus isolated from vaginal samples: a 10-year retrospective study in Hungary. Acta Dermatovenerol Alp Pannonica Adriat. 2019 Dec;28(4):143-147.

Ozsvár D, Nagy V, Zupkó I, Szakonyi Z. Stereoselective Synthesis and Antiproliferative Activity of Steviol-Based Diterpen Aminodiols. Int J Mol Sci. 2019 Dec 26;21(1). pii: E184. doi: 10.3390/ijms21010184.

Bartos C, Ambrus R, Katona G, Sovány T, Gáspár R, Márki Á, Ducza E, Ivanov A, Tömösi F, Janáky T, Szabó-Révész P. Transformation of Meloxicam Containing Nanosuspension into Surfactant-Free Solid Compositions to Increase the Product Stability and Drug Bioavailability for Rapid Analgesia. Drug Des Devel Ther. 2019 Nov 28;13:4007-4020. doi: 10.2147/DDDT.S220876.

Ducza E, Csányi A, Szőke É, Pohóczky K, Hajagos-Tóth J, Kothencz A, Tiszai Z, Gáspár R. Significance of transient receptor potential vanilloid 4 and aquaporin 5 co-expression in the rat uterus at term. Heliyon. 2019 Oct 22;5(10):e02697. doi: 10.1016/j.heliyon.2019.e02697

Kiss A, Wölfling J, Mernyák E, Frank É, Benke Z, Ashkan Senobar Tahaei S, Zupkó I, Mahó S, Schneider G. Stereocontrolled synthesis of the four possible 3-methoxy and 3-benzyloxy-16-triazolyl-methyl-estra-17-ol hybrids and their antiproliferative activities. Steroids. 2019 Dec

Tastan P, Hajdú Z, Kúsz N, Zupkó I, Sinka I, Kivcak B, Hohmann J. Sesquiterpene Lactones and Flavonoids from Psephellus pyrrhoblepharus with Antiproliferative Activity on Human Gynecological Cancer Cell Lines. Molecules. 2019 Aug 30;24(17).

Kiss A, Wölfling J, Mernyák E, Frank É, Gyovai A, Kulmány Á, Zupkó I, Schneider G. Stereoselective synthesis of new type of estradiol hybrid molecules and their antiproliferative activities. Steroids. 2019 Aug;148:63-72. doi: 10.1016/j.steroids.2019.02.016. Epub 2019 May 11.

Spengler G, Kincses A, Mosolygó T, Marc MA, Nové M, Gajdács M, Sanmartín C, McNeil HE, Blair JMA, Domínguez-Álvarez E. Antiviral, Antimicrobial and Antibiofilm Activity of Selenoesters and Selenoanhydrides, Molecules (2019) 24(23); doi.org/10.3390/molecules24234264

Latif AD, Gonda T, Vágvölgyi M, Kúsz N, Kulmány Á, Ocsovszki I, Zomborszki ZP, Zupkó I, Hunyadi A. Synthesis and In Vitro Antitumor Activity of Naringenin Oxime and Oxime Ether Derivatives. Int J Mol Sci. (2019) 2;20 doi: 10.3390/ijms20092184.

Büki A, Horvath G, Benedek G, Ducza E, Kekesi G. Impaired GAD1 expression in schizophrenia-related WISKET rat model with sex-dependent aggressive behavior and motivational deficit. Genes Brain Behav. 2019 Apr;18(4):e12507. doi: 10.1111/gbb.12507.

Mótyán G, Gopisetty MK, Kiss-Faludy RE, Kulmány Á, Zupkó I, Frank É, Kiricsi M. Anti-Cancer Activity of Novel Dihydrotestosterone-Derived Ring A-Condensed Pyrazoles on Androgen Non-Responsive Prostate Cancer Cell Lines. Int J Mol Sci. 2019 May 2;20(9). doi: 10.3390/ijms20092170.

Domokos D, Ducza E, Gáspár R. RhoA and Rho-kinase inhibitors modulate cervical resistance: The possible role of RhoA/Rho-kinase signalling pathway in cervical ripening and contractility. Eur J Pharmacol. 2019 Jan 15;843:27-33. doi: 10.1016/j.ejphar.2018.11.017.

Gajdács M, Urbán E: Epidemiological Trends and Resistance Associated with Stenotrophomonas maltophilia Bacteremia: A 10-Year Retrospective Cohort Study in a Tertiary-Care Hospital in Hungary. Diseases 2019, 7(2), 41; https://doi.org/10.3390/diseases7020041

Gajdács M: Resistance trends and epidemiology of Aeromonas and Plesiomonas infections (RETEPAPI): a 10-year retrospective survey. INFECTIOUS DISEASES 51 : 9 pp. 710-713. https://doi.org/10.1080/23744235.2019.1640389

Gajdács M, Urbán E: The relevance of anaerobic bacteria in brain abscesses: a ten-year retrospective analysis (2008–2017). INFECTIOUS DISEASES 51 : 10 pp. 779-781. https://doi.org/10.1080/23744235.2019.1648857

Gajdács M, Urbán E: Prevalence and Antibiotic Resistance of Stenotrophomonas maltophilia in Respiratory Tract Samples: A 10-Year Epidemiological Snapshot. HEALTH SERVICES RESEARCH AND MANAGERIAL EPIDEMIOLOGY 6 Paper: UNSP 2333392819870774. https://doi.org/10.1177/2333392819870774

Gajdács M, Urbán E, Terhes G: Microbiological and Clinical Aspects of Cervicofacial Actinomyces Infections: An Overview. Dentistry Journal 2019, 7(3), 85; https://doi.org/10.3390/dj7030085

Gajdács M, Albericio F: Antibiotic Resistance: From the Bench to Patients 2019, 8(3), 129; https://doi.org/10.3390/antibiotics8030129

Gajdács M, Burián K, Terhes G: Resistance Levels and Epidemiology of Non-Fermenting Gram-Negative Bacteria in Urinary Tract Infections of Inpatients and Outpatients (RENFUTI): A 10-Year Epidemiological Snapshot. Antibiotics 2019, 8(3), 143; https://doi.org/10.3390/antibiotics8030143

Márió Gajdács, Ilona Dóczi , Marianna Ábrók , Andrea Lázár , Katalin Burián: Epidemiology of candiduria and Candida urinary tract infections in inpatients and outpatients: results from a 10-year retrospective survey Cent European J Urol. 72 (2019) doi: 10.5173/ceju.2019.1909

Gajdács M, Urbán E: Resistance Trends and Epidemiology of Citrobacter-Enterobacter-Serratia in Urinary Tract Infections of Inpatients and Outpatients (RECESUTI): A 10-Year Survey. Medicina 55(6), 285 (2019) doi:10.3390/medicina55060285

Gajdács M: Anaerobes and laboratory automation: Like oil and water? Anaerobe 59 (2019) doi: 10.1016/j.anaerobe.2019.06.009

Gajdács M, Urbán E: Comparative Epidemiology and Resistance Trends of Proteae in Urinary Tract Infections of Inpatients and Outpatients: A 10-Year Retrospective Study. 8(3) (2019) doi: 10.3390/antibiotics8030091

Gajdács M, Ábrók M, Lázár A, Burián K: Comparative Epidemiology and Resistance Trends of Common Urinary Pathogens in a Tertiary-Care Hospital: A 10-Year Surveillance Study. Medicina 55(7), 365 (2019) doi: 10.3390/medicina55070356

Gajdács M: The Continuing Threat of Methicillin-Resistant Staphylococcus aureus. Antibiotics 8(2), 52 (2019) doi: 10.3390/antibiotics8020052

Gajdács M: The Concept of an Ideal Antibiotic: Implications for Drug Design. Molecules 24(5), 892 (2019) doi: 10.3390/molecules24050892